A masterpiece in post-treatment skincare, SkinMedica TNS Ceramide Treatment Cream delivers gentle yet profound care, restoring balance and radiance to your skin. Specially crafted for dry, sensitive, or post-procedure skin, this cream offers a soothing spa-like experience from the comfort of your home.
Key Benefits of SkinMedica TNS Ceramide Treatment Cream:
✨ Enhanced with peptides: Supports collagen production to reduce the appearance of fine lines and wrinkles.
✨ Balances skin moisture levels: Gentle formulation keeps skin soft and hydrated.
✨ Aids in post-procedure recovery: Calms and restores irritated or sensitive skin.
✨ TNS Growth Factor Blend: Proprietary ingredient that promotes cellular regeneration and combats aging.
Star Ingredients:
- Human Fibroblast Conditioned Media (TNS®):
- A proprietary bio-rich blend packed with natural nutrients, boosting epidermal cell regeneration and reducing aging signs.
- Ceramide:
- Builds a protective barrier to shield the skin from environmental aggressors, keeping it smooth and supple.
- Palmitoyl Oligopeptide & Tetrapeptide-7:
- Advanced peptides that stimulate collagen production, minimizing wrinkles and enhancing skin elasticity.
Main Functions:
🌸 Soothes and calms irritated skin after treatments.
🌸 Restores natural moisture balance, reducing redness and dryness.
🌸 Enhances the skin’s protective barrier for a youthful, plump appearance.
Detailed Ingredients:
🌿 Natural Extracts: Olive oil, soybean oil, and oat extract nourish and protect the skin.
💧 Deep Hydration Agents: Sodium Hyaluronate and Glycerin lock in moisture for long-lasting hydration.
🌟 Anti-aging Components: Retinyl Palmitate and Tocopheryl Acetate (Vitamin E) ensure smooth, glowing, and youthful skin.
How to Use:
- Use morning and night after cleansing, toning, and applying serum.
- Take an appropriate amount and gently apply to the face, neck, and chest.
- Massage lightly for better absorption.
🌟 Note: Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Reviews
There are no reviews yet.